ABT-450/r/ABT-267
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for ABT-450/r/ABT-267, covering 2015-01-06 to 2023-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection [Phase 3]